ATE240346T1 - Leberspezifische gallensaeurederivate des antiglukokorticoids ru486 - Google Patents
Leberspezifische gallensaeurederivate des antiglukokorticoids ru486Info
- Publication number
- ATE240346T1 ATE240346T1 AT00922530T AT00922530T ATE240346T1 AT E240346 T1 ATE240346 T1 AT E240346T1 AT 00922530 T AT00922530 T AT 00922530T AT 00922530 T AT00922530 T AT 00922530T AT E240346 T1 ATE240346 T1 AT E240346T1
- Authority
- AT
- Austria
- Prior art keywords
- antiglucorcorticoid
- liver
- acid derivatives
- bile acid
- specific bile
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9907048.4A GB9907048D0 (en) | 1999-03-27 | 1999-03-27 | Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders |
PCT/EP2000/002429 WO2000058337A1 (en) | 1999-03-27 | 2000-03-18 | Liver specific bile acid derivatives of the glucocorticoid antagonist ru486 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE240346T1 true ATE240346T1 (de) | 2003-05-15 |
Family
ID=10850457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00922530T ATE240346T1 (de) | 1999-03-27 | 2000-03-18 | Leberspezifische gallensaeurederivate des antiglukokorticoids ru486 |
Country Status (13)
Country | Link |
---|---|
US (1) | US6468975B1 (de) |
EP (1) | EP1165595B1 (de) |
JP (1) | JP2002540215A (de) |
KR (1) | KR20020002486A (de) |
AT (1) | ATE240346T1 (de) |
AU (1) | AU758654B2 (de) |
CA (1) | CA2367792A1 (de) |
DE (1) | DE60002692T2 (de) |
DK (1) | DK1165595T3 (de) |
ES (1) | ES2197091T3 (de) |
GB (1) | GB9907048D0 (de) |
PT (1) | PT1165595E (de) |
WO (1) | WO2000058337A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1267898A4 (de) * | 2000-04-07 | 2006-02-01 | Univ Maryland | Gallensäure enthaltend propharmaka mit erhöhter bioavibilität |
CA2488535C (en) * | 2002-06-19 | 2012-02-07 | Karo Bio Ab | Glucocorticoid receptor ligands for the treatment of metabolic disorders |
US7141559B2 (en) | 2002-06-19 | 2006-11-28 | Karo Bio Ab | Glucocorticoid receptor ligands for the treatment of metabolic disorders |
WO2010052445A1 (en) | 2008-11-07 | 2010-05-14 | University Of Sheffield | Medicament and method of diagnosis |
RU2014119787A (ru) | 2011-10-25 | 2015-12-10 | Айсис Фармасьютикалс, Инк. | Антисмысловая регуляция экспрессии gccr |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2441129A (en) | 1942-05-23 | 1948-05-11 | Berczeller Arpad | Bile acid derivatives of aryl sulfonamides |
US4418059A (en) | 1981-07-20 | 1983-11-29 | Montefiore Medical Center | Nucleoside ester compositions |
DE3930696A1 (de) * | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
WO1998027986A1 (en) | 1996-12-24 | 1998-07-02 | Zymogenetics, Inc. | Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes |
WO1999063976A2 (en) | 1998-06-08 | 1999-12-16 | Karo Bio Ab | Liver-selective glucocorticoid antagonist for treating diabetes |
-
1999
- 1999-03-27 GB GBGB9907048.4A patent/GB9907048D0/en not_active Ceased
-
2000
- 2000-03-18 AU AU42893/00A patent/AU758654B2/en not_active Ceased
- 2000-03-18 PT PT00922530T patent/PT1165595E/pt unknown
- 2000-03-18 DE DE60002692T patent/DE60002692T2/de not_active Expired - Lifetime
- 2000-03-18 US US09/937,374 patent/US6468975B1/en not_active Expired - Fee Related
- 2000-03-18 WO PCT/EP2000/002429 patent/WO2000058337A1/en not_active Application Discontinuation
- 2000-03-18 KR KR1020017012347A patent/KR20020002486A/ko not_active Application Discontinuation
- 2000-03-18 DK DK00922530T patent/DK1165595T3/da active
- 2000-03-18 AT AT00922530T patent/ATE240346T1/de not_active IP Right Cessation
- 2000-03-18 CA CA002367792A patent/CA2367792A1/en not_active Abandoned
- 2000-03-18 JP JP2000608037A patent/JP2002540215A/ja active Pending
- 2000-03-18 ES ES00922530T patent/ES2197091T3/es not_active Expired - Lifetime
- 2000-03-18 EP EP00922530A patent/EP1165595B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1165595A1 (de) | 2002-01-02 |
EP1165595B1 (de) | 2003-05-14 |
JP2002540215A (ja) | 2002-11-26 |
WO2000058337A1 (en) | 2000-10-05 |
CA2367792A1 (en) | 2000-10-05 |
AU4289300A (en) | 2000-10-16 |
DK1165595T3 (da) | 2003-09-15 |
PT1165595E (pt) | 2003-08-29 |
KR20020002486A (ko) | 2002-01-09 |
AU758654B2 (en) | 2003-03-27 |
DE60002692D1 (de) | 2003-06-18 |
US6468975B1 (en) | 2002-10-22 |
GB9907048D0 (en) | 1999-05-19 |
ES2197091T3 (es) | 2004-01-01 |
DE60002692T2 (de) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021358D0 (no) | Alkylendiamin-substituerte heterocykler | |
TR200100238T2 (tr) | Yeni sübstitüe edilmiş pirazol türevleri | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
DE60037892D1 (de) | Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis | |
NO20045043L (no) | Pyrimidinonforbindelser, sammensetninger og fremgangsmater | |
WO2005030120A3 (en) | Antiangiogenic agents | |
ATE284853T1 (de) | Ureido-thiobuttersäurederivate als ppar-agonisten | |
ATE304354T1 (de) | Kaliumkanal-modulierende imidazolderivate | |
WO2002042319A3 (en) | 2-substituted estrogens as antiangiogenic agents | |
DE602004007672D1 (de) | Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate | |
ATE269340T1 (de) | Thiazolopyrimidine und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität | |
NZ516397A (en) | Aminothiazole derivatives and their use as CRF receptor ligands | |
ATE240346T1 (de) | Leberspezifische gallensaeurederivate des antiglukokorticoids ru486 | |
DE60311887D1 (de) | Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung | |
ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
DK1196442T3 (da) | VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser | |
ATE517626T1 (de) | Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen | |
DE50114181D1 (de) | Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz | |
ATE322244T1 (de) | Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
ATE357914T1 (de) | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien | |
DK1368023T3 (da) | Anvendelse af buprenoprphin til behandling af urininkontinens | |
DK1196428T3 (da) | 11-beta-aryl-17,17-spirothiolan-substituerede steroider | |
PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
ATE298244T1 (de) | Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1165595 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |